ARCHIVES

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 34 | September 4, 1992

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

Dana-Farber Opens Imaging Center

May 8, 2009

“Hop” May Include 100-200 Hospitals, Funded At Total Of $10 Million A Year, Should Start In FY 1982; DeVita

June 19, 1981

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014